|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 1/10/06 Angiodynamics Inc 10-Q 11/26/05 7:1.8M RR Donnelley/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 337K
2: EX-10.1 Supply and Distribution Rights Agreement Dated HTML 227K
October 17, 2005
3: EX-10.2 First Amendment to Distribution Agreement Dated HTML 162K
June 22, 2004
4: EX-31.1 Section 302 CEO Certification HTML 12K
5: EX-31.2 Section 302 CFO Certification HTML 12K
6: EX-32.1 Section 906 CEO Certification HTML 8K
7: EX-32.2 Section 906 CFO Certification HTML 8K
| Section 906 CEO Certification |
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO TITLE 18,
UNITED STATES CODE, SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Eamonn P. Hobbs, President, Chief Executive Officer and Director of AngioDynamics, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that,:
| 1. | the Quarterly Report on Form 10-Q of the Company for the quarter ended August 27, 2005 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date January 10, 2006 | /s/ Eamonn P. Hobbs | |
| Eamonn P. Hobbs, President, | ||
| Chief Executive Officer |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 1/10/06 | 4 | ||
| For Period End: | 11/26/05 | |||
| 8/27/05 | 10-Q | |||
| List all Filings | ||||